Rieneke van de Ven

11PUBLICATIONS
48CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 11, 2025
Commentary on differential impact of TIM-3 ligands on NK cell function.

Rieneke van de Ven

|Jan 11, 2025
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease.

Irene H Nauta, Dennis N L M Nijenhuis, Sonja H Ganzevles

|Sep 09, 2024
Secretome and immune cell attraction analysis of head and neck cancers.

Tara Muijlwijk, Niels E Wondergem, Fatima Ekhlas

|Jul 25, 2024
Immune cell topography of head and neck cancer.

Tara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles

|Jul 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer.

Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven

|Jun 17, 2024
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS986-192 PET: pooled analysis of data from four solid tumor types.

Iris H C Miedema, Johanna E E Pouw, Anne Kwakman

Pageof 2

Frequent Collaborators

4 joint publications

C René Leemans

3 joint publications

Ruud H Brakenhoff

3 joint publications

Elisabeth Bloemena

3 joint publications

Iris H C Miedema